Privia Health Group Inc
NASDAQ:PRVA

Watchlist Manager
Privia Health Group Inc Logo
Privia Health Group Inc
NASDAQ:PRVA
Watchlist
Price: 23.15 USD -4.34% Market Closed
Market Cap: 2.8B USD

Privia Health Group Inc
Investor Relations

Privia Health Group Inc. is a compelling tale of innovation in the healthcare space, driven by its unique approach to physician enablement. Founded on the principle of enhancing the operational efficiency of medical practices, Privia Health partners with physicians to help them deliver high-quality care while navigating the complexities of modern healthcare systems. By providing a robust technology platform alongside a comprehensive suite of clinical, financial, and operational services, Privia empowers doctors to maintain their independence while benefiting from the support and scale typically enjoyed by larger healthcare organizations. This model not only enhances patient care but also aligns with value-based care initiatives by focusing on outcomes rather than solely on the volume of services provided.

The company's revenue engine is fueled by several streams. Primarily, Privia generates earnings through management service agreements with the practices it partners with. These agreements involve sharing savings that result from improved care coordination and operational efficiencies, part of which are attributed to the physicians and part retained by Privia. Additionally, the organization benefits from its participation in value-based care contracts, where performance metrics tied to quality and cost can lead to shared savings arrangements with payers. This alignment of interests between Privia, the physicians, and the payers forms a sustainable business model that prioritizes both profitability and improved patient outcomes, setting a new benchmark in the healthcare landscape.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2025
Call Date
Nov 6, 2025
AI Summary
Q3 2025

Strong Quarter: Privia Health reported robust Q3 results, with significant revenue and margin growth driven by new provider additions and strong value-based care performance.

Guidance Raised: Management increased full-year 2025 guidance above previous ranges, citing continued momentum and visibility into 2026.

Margin Expansion: Adjusted EBITDA margin as a percentage of care margin expanded by 720 basis points year-over-year, reaching 30.5%.

Practice Collections: Practice collections grew 27.1% year-over-year in Q3, outpacing provider growth and reflecting strong utilization trends and new market contributions.

Evolent Acquisition: Privia is acquiring Evolent Health’s ACO business, adding over 120,000 attributed lives and expanding to six new states; the deal is expected to close by year-end and contribute to EBITDA in 2026.

Diversified Value-Based Book: Growth in attributed lives was broad-based across commercial, Medicare, and Medicaid, each up over 12% year-over-year.

Cash Position: Pro forma cash at quarter-end was $409.9 million with no debt, supporting continued business development and potential M&A.

Capitated MA Business: The Medicare Advantage capitation book remains small but profitable; management remains cautious about growing this segment given industry headwinds.

Key Financials
Implemented Providers
5,250
Total Attributed Lives
1.4 million
Practice Collections
$940.4 million
Adjusted EBITDA
$38.2 million
EBITDA Margin as % of Care Margin
30.5%
Aggregate Medicare Shared Savings Program Savings Rate
9.4%
Total Shared Savings
$234.1 million
Gross Shared Savings Recognized
$160.1 million
Free Cash Flow (year-to-date, pro forma)
$104.4 million
Pro Forma Cash (quarter-end)
$409.9 million
Commercial Attributed Lives
864,000
Earnings Call Recording
Other Earnings Calls

Management

Mr. Parth Mehrotra
CEO & Director
No Bio Available
Mr. David Mountcastle CPA, MBA
Executive VP, CFO & Principal Accounting Officer
No Bio Available
Mr. Sarath Degala
Chief Operating Officer
No Bio Available
Mr. Chris Voigt
Executive VP & Chief Technology Officer
No Bio Available
Mr. Robert P. Borchert
Senior Vice President of Investor Relations & Corporate Communications
No Bio Available
Ms. Dana Fields CPA
Chief Audit & Compliance Officer
No Bio Available
Mr. Edward Christopher Fargis Esq.
Executive VP, General Counsel, Chief Legal Officer & Corporate Secretary
No Bio Available
Ms. Jenny Harding
Chief People Officer
No Bio Available
Mr. Jay Stevens
Senior VP & Chief Growth Officer
No Bio Available
Mr. Eric J. Beyer
Executive Vice President of Medical Groups
No Bio Available

Contacts

Address
VIRGINIA
Arlington
950 N. Glebe Rd., Suite 700
Contacts
+15713668850.0
www.priviahealth.com